Obsidian Therapeutics Inc. (OBX) vs Passage Bio, Inc. (PASG)
A side-by-side comparison of Obsidian Therapeutics Inc. and Passage Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OBX
Obsidian Therapeutics Inc.
$13.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PASG
Passage Bio, Inc.
$4.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — OBX vs PASG
growth of $100 · dividends reinvested · last 1yOBX -20.9% (-20.9%/yr)PASG -17.2% (-17.2%/yr)PASG compounded faster over this window
OBX PASG
Metrics side by side
Total return (annualized)
| Metric | OBX | PASG |
|---|---|---|
| Total return (1Y) | N/A | -48.39% |
| Total return CAGR (3Y) | N/A | -31.45% |
| Total return CAGR (5Y) | N/A | -53.23% |
OBX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.